RxDoctor Payments Data
★ My doctorsLook up a doctor →

Marlene Hart

Psychiatry · Wesley Chapel, FLNPI 1851364046

Payments from drug & device makers

$406,799in general payments, 2019–2025

Across 86 payments — averaging $4730.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Supernus Pharmaceuticals, Inc.$315K
  • Sage Therapeutics, LLC$92K
  • Neurocrine Biosciences, Inc.$229
  • E.r. Squibb & Sons, L.L.C.$122
  • Johnson & Johnson$92
  • Takeda Pharmaceuticals U.S.A., Inc.$48
  • plus $98 from 4 others
$2,082in research payments, 2019–2025

Across 16 payments — averaging $130.15 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Supernus Pharmaceuticals, Inc.$2K

What the payments were for

  • Food & beverage$588100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Supernus Pharmaceuticals, Inc.46$314,675
Sage Therapeutics, LLC21$91,536
Neurocrine Biosciences, Inc.7$229
E.r. Squibb & Sons, L.L.C.1$122
Johnson & Johnson5$92
Takeda Pharmaceuticals U.S.A., Inc.1$48
Sunovion Pharmaceuticals Inc.2$39
Indivior Inc.1$26
GSK1$18
Teva Pharmaceuticals USA, Inc.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$406,799 in reported general payments places this provider in the 95th percentile of 2,059 psychiatry providers in Florida.

See all psychiatry providers in Florida →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate25$58,946
TrintellixVortioxetine Hydrobromide38$25,243
Lurasidone Hcl13$18,599
Lamotrigine OdtLamotrigine12$7,647
XanaxAlprazolam12$7,015
Aripiprazole26$2,052
Oxcarbazepine40$1,937
Ziprasidone Hcl25$1,834
Quetiapine Fumarate ErQuetiapine Fumarate31$805
Buspirone Hcl46$728
Mirtazapine17$608
Topiramate54$602
Lamotrigine19$527
Risperidone38$463
Hydroxyzine Pamoate27$377

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$92$58,94625 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$48$25,24338 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,059 psychiatry providers in Florida.

Other psychiatry in Wesley Chapel

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →